Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 2:13:817020.
doi: 10.3389/fphar.2022.817020. eCollection 2022.

Tag-SNPs in Phospholipase-Related Genes Modify the Susceptibility to Nephrosclerosis and its Associated Cardiovascular Risk

Luz M González  1 , Nicolás R Robles  2   3 , Sonia Mota-Zamorano  1   3 , José C Arévalo-Lorido  4 , José Manuel Valdivielso  5   3 , Juan López-Gómez  6 , Guillermo Gervasini  1   3
Affiliations

Tag-SNPs in Phospholipase-Related Genes Modify the Susceptibility to Nephrosclerosis and its Associated Cardiovascular Risk

Luz M González et al. Front Pharmacol. .

Abstract

Nephrosclerosis patients have a high cardiovascular (CV) risk that is very often of more concern than the renal disease itself. We aimed to determine whether variants in phospholipase-related genes, associated with atherosclerosis and CV outcomes in the general population, could constitute biomarkers of nephrosclerosis and/or its associated CV risk. We screened 1,209 nephrosclerosis patients and controls for 86 tag-SNPs that were identified in the SCARB1, PLA2G4A, and PLA2G7 gene loci. Regression models were utilized to evaluate their effect on several clinical parameters. Most notably, rs10846744 and rs838880 in SCARB1 showed significant odds ratios (OR) of 0.66 (0.51-0.87), p = 0.003 and 1.48 (1.11-1.96), p = 0.007 for nephrosclerosis risk. PLA2G4A and PLA2G7 harboured several SNPs associated with atherosclerosis measurements in the patients, namely common carotid intima media thickness (ccIMT), presence of plaques, number of plaques detected and 2-years ccIMT progression (significant p-values ranging from 0.0004 to 0.047). Eight SNPs in PLA2G4A were independent risk factors for CV events in nephrosclerosis patients. Their addition to a ROC model containing classic risk factors significantly improved its predictive power from AUC = 69.1% (61.4-76.9) to AUC = 79.1% (73.1-85.1%), p = 0.047. Finally, PLA2G4A rs932476AA and rs6683619AA genotypes were associated with lower CV event-free survival after controlling for confounding variables [49.59 (47.97-51.21) vs. 51.81 (49.93-51.78) months, p = 0.041 and 46.46 (41.00-51.92) vs. 51.17 (50.25-52.08) months, p = 0.022, respectively]. Variability in phospholipase-related genes play a relevant role in nephrosclerosis and associated atherosclerosis measurements and CV events.

Keywords: atherosclerosis; cardiovascular risk; nephrosclerosis; phospholipases; single nucleotide polymorphism.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Association between tag-SNPs in the PLA2G7 gene with atherosclerosis-related measurements. The dotted line denotes the level of statistical significance. ccIMT, common carotid intima media thickness (mm).
FIGURE 2
FIGURE 2
Association between tag-SNPs in the PLA2G4A gene with atherosclerosis-related measurements. The dotted line denotes the level of statistical significance.
FIGURE 3
FIGURE 3
Receiving Operating Curves for the risk of cardiovascular events in (A) nephrosclerosis patients and (B) the whole population of patients and controls. The blue line corresponds to the model with classic risk factors and the green line corresponds to the same model when genetic information is added. AUC, area under the curve.
FIGURE 4
FIGURE 4
Kaplan-Meier curves of the association of two PLA2G4A polymorphisms, rs932476 (A) and rs6683619 (B), with CV event-free survival.
See this image and copyright information in PMC

References

    1. Abajo M., Betriu À., Arroyo D., Gracia M., Del Pino M. D., Martínez I., et al. (2017). Mineral Metabolism Factors Predict Accelerated Progression of Common Carotid Intima-media Thickness in Chronic Kidney Disease: the NEFRONA Study. Nephrol. Dial. Transpl. 32 (11), 1882–1891. 10.1093/ndt/gfw306 - DOI - PubMed
    1. Arroyo D., Betriu A., Martinez-Alonso M., Vidal T., Valdivielso J. M., Fernández E. (2014). Observational Multicenter Study to Evaluate the Prevalence and Prognosis of Subclinical Atheromatosis in a Spanish Chronic Kidney Disease Cohort: Baseline Data from the NEFRONA Study. BMC Nephrol. 15, 168. 10.1186/1471-2369-15-168 - DOI - PMC - PubMed
    1. Bonetti A., Allegri L., Baldan F., Contin M., Battistella C., Damante G., et al. (2020). Critical Involvement of Calcium-dependent Cytosolic Phospholipase A2α in Aortic Valve Interstitial Cell Calcification. Int. J. Mol. Sci. 21 (17), 6398. 10.3390/ijms21176398 - DOI - PMC - PubMed
    1. Casas J. P., Ninio E., Panayiotou A., Palmen J., Cooper J. A., Ricketts S. L., et al. (2010). PLA2G7 Genotype, Lipoprotein-Associated Phospholipase A2 Activity, and Coronary Heart Disease Risk in 10 494 Cases and 15 624 Controls of European Ancestry. Circulation 121 (21), 2284–2293. 10.1161/CIRCULATIONAHA.109.923383 - DOI - PMC - PubMed
    1. Cho K. H., Kim H. J., Kamanna V. S., Vaziri N. D. (2010). Niacin Improves Renal Lipid Metabolism and Slows Progression in Chronic Kidney Disease. Biochim. Biophys. Acta 1800 (1), 6–15. 10.1016/j.bbagen.2009.10.009 - DOI - PubMed